Correlation between Chemokine Receptor CXCR4 Expression and Prognostic Factors in Patients with Prostate Cancer

scientific article published on 28 September 2011

Correlation between Chemokine Receptor CXCR4 Expression and Prognostic Factors in Patients with Prostate Cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.4111/KJU.2011.52.9.607
P932PMC publication ID3198233
P698PubMed publication ID22025955
P5875ResearchGate publication ID51744031

P2093author name stringChun Il Kim
Mi Sun Choi
Byung Hoon Kim
Choal Hee Park
Hyea Ra Jung
Hyuk Soo Chang
Seok Jin Jung
P2860cites workUse of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to boneQ60504419
Expression of CXCR4 Predicts Poor Prognosis in Patients with Malignant MelanomaQ63247804
Acute inflammatory effects of a monocyte-derived neutrophil-activating peptide in rabbit skinQ69520475
Chemokines trigger immediate beta2 integrin affinity and mobility changes: differential regulation and roles in lymphocyte arrest under flowQ73406513
T140 analogs as CXCR4 antagonists identified as anti-metastatic agents in the treatment of breast cancerQ73847638
Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cellsQ78710357
Chemokine receptor CXCR4 expression and prognosis in patients with metastatic prostate cancerQ80506644
Prostate tumor CXC-chemokine profile correlates with cell adhesion to endothelium and extracellular matrixQ81428298
Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progressionQ83187267
Involvement of chemokine receptors in breast cancer metastasisQ24290909
Actin-based cell motility and cell locomotionQ28276582
CXCR4 regulates growth of both primary and metastatic breast cancerQ28296113
Chemokines: a new classification system and their role in immunityQ29615663
Persistent CXCR4 expression after preoperative chemoradiotherapy predicts early recurrence and poor prognosis in esophageal cancerQ33868710
The role of chemokines in melanoma tumor growth and metastasisQ34680888
Potential clinical applications of the CXCR4 antagonist bicyclam AMD3100.Q36264524
A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors.Q37089440
Metabolomics: a novel approach to early and noninvasive prostate cancer detection.Q37850315
Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasisQ40538377
A single treatment with microcapsules containing a CXCR4 antagonist suppresses pulmonary metastasis of murine melanomaQ40543358
Expression pattern of chemokine receptor 6 (CCR6) and CCR7 in squamous cell carcinoma of the head and neck identifies a novel metastatic phenotype.Q40583095
Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cellsQ40692637
Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancerQ40696855
Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancerQ47272097
Transendothelial migration and trafficking of leukocytes in LFA-1-deficient miceQ47915830
Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcomeQ47917544
P275copyright licenseCreative Commons Attribution-NonCommercial 3.0 UnportedQ18810331
P6216copyright statuscopyrightedQ50423863
P433issue9
P921main subjectprostate cancerQ181257
P304page(s)607-611
P577publication date2011-09-28
P1433published inKorean Journal of UrologyQ26842099
P1476titleCorrelation between Chemokine Receptor CXCR4 Expression and Prognostic Factors in Patients with Prostate Cancer
P478volume52

Reverse relations

cites work (P2860)
Q48045458Abortifacient metapristone (RU486 derivative) interrupts CXCL12/CXCR4 axis for ovarian metastatic chemoprevention.
Q59104388CXCR4 Expression in Gastric Cancer and Bone Marrow: Association with Hypoxia-Regulated Indices, Disseminated Tumor Cells, and Patients Survival
Q45122565CXCR4 is highly expressed at the tumor front but not in the center of prostate cancers
Q28084663CXCR4 over-expression and survival in cancer: a system review and meta-analysis
Q60931267Chemokines and Chemokine Receptors: Orchestrating Tumor Metastasization
Q86814803Chemokines in tumor progression and metastasis
Q34451400Clinical significance of nuclear factor κB and chemokine receptor CXCR4 expression in patients with diffuse large B-cell lymphoma who received rituximab-based therapy
Q37359760Differing leukocyte gene expression profiles associated with fatigue in patients with prostate cancer versus chronic fatigue syndrome
Q37225329Emerging targets in cancer management: role of the CXCL12/CXCR4 axis
Q39402696Emodin inhibits invasion and migration of prostate and lung cancer cells by downregulating the expression of chemokine receptor CXCR4.
Q95924579Evaluation of Somatostatin and CXCR4 Receptor Expression in a Large Set of Prostate Cancer Samples Using Tissue Microarrays and Well-Characterized Monoclonal Antibodies
Q40449073Expression of CXC chemokine receptor-4 and forkhead box 3 in neuroblastoma cells and response to chemotherapy.
Q89998115Fibroblast-derived CXCL12 regulates PTEN expression and is associated with the proliferation and invasion of colon cancer cells via PI3k/Akt signaling
Q33555276High CXC chemokine receptor 4 expression is an adverse prognostic factor in patients with clear-cell renal cell carcinoma
Q28393898Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells
Q41550917Meta-Analysis of the Relationship between CXCR4 Expression and Metastasis in Prostate Cancer.
Q37116576PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling
Q39424549Prostate Cancer Stem Cell Markers Drive Progression, Therapeutic Resistance, and Bone Metastasis
Q35213463Targeting chemokine receptor CXCR4 for treatment of HIV-1 infection, tumor progression, and metastasis
Q26785506The association of CXCR4 expression with clinicopathological significance and potential drug target in prostate cancer: a meta-analysis and literature review
Q39013775The influence of lentivirus-mediated CXCR4 RNA interference on hepatic metastasis of colorectal cancer
Q34927102Upregulated expression of C-X-C chemokine receptor 4 is an independent prognostic predictor for patients with gastric cancer
Q35195342miR-1 and miR-133b are differentially expressed in patients with recurrent prostate cancer

Search more.